Texas Attorney General Ken Paxton announced a landmark settlement with Pieces Technologies, a generative AI healthcare company. The settlement addresses allegations that Pieces misrepresented the accuracy of its AI-powered services, violating the Texas Deceptive Trade Practices Consumer Protection Act. This case highlights the increasing scrutiny of AI technologies in healthcare settings and the importance of transparency in marketing.
The settlement requires Pieces to implement clear disclosures in its marketing and prohibits misleading claims about its products. This action reflects a broader trend of regulatory bodies closely monitoring AI applications, especially in high-risk sectors like healthcare. Companies must now prioritize responsible AI deployment to avoid regulatory repercussions.
• Texas AG secures settlement with Pieces Technologies for deceptive marketing practices.
• Regulatory scrutiny on AI in healthcare is increasing significantly.
Pieces Technologies utilizes generative AI to automate clinical tasks in healthcare settings.
The Texas AG's case against Pieces was based on allegations of such practices.
Pieces Technologies offers AI-powered services to assist healthcare professionals in managing patient data.
The company faced allegations of misleading marketing practices regarding the accuracy of its AI products.
Western Mass News 18month
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.